These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 21278081)

  • 1. Functional and systems biology approaches to Huntington's disease.
    González-Couto E
    Brief Funct Genomics; 2011 May; 10(3):109-14. PubMed ID: 21278081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excitotoxic neuronal death and the pathogenesis of Huntington's disease.
    Estrada Sánchez AM; Mejía-Toiber J; Massieu L
    Arch Med Res; 2008 Apr; 39(3):265-76. PubMed ID: 18279698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Huntington's disease, calcium, and mitochondria.
    Giacomello M; Hudec R; Lopreiato R
    Biofactors; 2011; 37(3):206-18. PubMed ID: 21674644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presynaptic dysfunction in Huntington's disease.
    Rozas JL; Gómez-Sánchez L; Tomás-Zapico C; Lucas JJ; Fernández-Chacón R
    Biochem Soc Trans; 2010 Apr; 38(2):488-92. PubMed ID: 20298208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Huntington's disease: clinical and molecular genetics].
    Warita H; Shiro Y; Kashihara K; Abe K
    Nihon Rinsho; 1999 Apr; 57(4):896-9. PubMed ID: 10222786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular biology of Huntington's disease.
    McFarland KN; Cha JH
    Handb Clin Neurol; 2011; 100():25-81. PubMed ID: 21496570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Huntington's disease: which drugs might help patients?
    Hannan AJ
    IDrugs; 2004 Apr; 7(4):351-8. PubMed ID: 15057641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Huntington's disease: the current state of research with peripheral tissues.
    Sassone J; Colciago C; Cislaghi G; Silani V; Ciammola A
    Exp Neurol; 2009 Oct; 219(2):385-97. PubMed ID: 19460373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective neuronal degeneration in Huntington's disease.
    Cowan CM; Raymond LA
    Curr Top Dev Biol; 2006; 75():25-71. PubMed ID: 16984809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathophysiology of Huntington's disease: an update].
    Roze E; Betuing S; Deyts C; Vidailhet M; Caboche J
    Rev Neurol (Paris); 2008 Dec; 164(12):977-94. PubMed ID: 18808762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Huntington's disease-like syndromes: what to consider in patients with a negative Huntington's disease gene test.
    Schneider SA; Walker RH; Bhatia KP
    Nat Clin Pract Neurol; 2007 Sep; 3(9):517-25. PubMed ID: 17805246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The molecular bases of Huntington's disease: the role played by oxidative stress].
    Tasset I; Sánchez F; Túnez I
    Rev Neurol; 2009 Oct 16-31; 49(8):424-9. PubMed ID: 19816846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of huntingtin pathologic fragments in human Huntington disease, transgenic mice, and cell models.
    Schilling G; Klevytska A; Tebbenkamp AT; Juenemann K; Cooper J; Gonzales V; Slunt H; Poirer M; Ross CA; Borchelt DR
    J Neuropathol Exp Neurol; 2007 Apr; 66(4):313-20. PubMed ID: 17413322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Huntington's disease: roles of huntingtin-interacting protein 1 (HIP-1) and its molecular partner HIPPI in the regulation of apoptosis and transcription.
    Bhattacharyya NP; Banerjee M; Majumder P
    FEBS J; 2008 Sep; 275(17):4271-9. PubMed ID: 18637945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of disease: Histone modifications in Huntington's disease.
    Sadri-Vakili G; Cha JH
    Nat Clin Pract Neurol; 2006 Jun; 2(6):330-8. PubMed ID: 16932577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent insights into the molecular pathogenesis of Huntington disease.
    Leavitt BR; Wellington CL; Hayden MR
    Semin Neurol; 1999; 19(4):385-95. PubMed ID: 10716661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Huntingtin protein: A new option for fixing the Huntington's disease countdown clock.
    Caterino M; Squillaro T; Montesarchio D; Giordano A; Giancola C; Melone MAB
    Neuropharmacology; 2018 Jun; 135():126-138. PubMed ID: 29526547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leptin secretion rate increases with higher CAG repeat number in Huntington's disease patients.
    Aziz NA; Pijl H; Frölich M; van der Graaf AW; Roelfsema F; Roos RA
    Clin Endocrinol (Oxf); 2010 Aug; 73(2):206-11. PubMed ID: 19548952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What have we learned from gene expression profiles in Huntington's disease?
    Seredenina T; Luthi-Carter R
    Neurobiol Dis; 2012 Jan; 45(1):83-98. PubMed ID: 21820514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigating the Transition of Pre-Symptomatic to Symptomatic Huntington's Disease Status Based on Omics Data.
    Christodoulou CC; Zachariou M; Tomazou M; Karatzas E; Demetriou CA; Zamba-Papanicolaou E; Spyrou GM
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33049985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.